ProfileGDS4132 / 221038_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 21% 21% 24% 19% 25% 20% 20% 27% 20% 24% 21% 19% 25% 23% 16% 20% 17% 25% 16% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10148.176221
GSM201543Muscle PCOS pioglitazone 12139.576321
GSM201544Muscle PCOS pioglitazone 16157.795524
GSM201545Muscle PCOS pioglitazone 20146.420919
GSM201829Muscle PCOS pioglitazone 23164.319525
GSM201830Muscle PCOS pioglitazon 25145.629120
GSM201831Muscle PCOS pioglitazone 27140.403520
GSM201832Muscle PCOS pioglitazone 3165.686427
GSM201833Muscle PCOS pioglitazone 4141.790320
GSM201834Muscle PCOS pioglitazone 8153.587124
GSM201835Muscle PCOS after pioglitazone 10236.121921
GSM201836Muscle PCOS after pioglitazone 12234.003519
GSM201837Muscle PCOS after pioglitazone 16245.912125
GSM201838Muscle PCOS after pioglitazone 20246.990923
GSM201839Muscle PCOS after pioglitazone 23228.495216
GSM201840Muscle PCOS after pioglitazone 25242.859820
GSM201841Muscle PCOS after pioglitazone 27227.647217
GSM201842Muscle PCOS after pioglitazone 3245.528325
GSM201843Muscle PCOS after pioglitazone 4233.572416
GSM201844Muscle PCOS after pioglitazone 8247.362223